Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Hologic MDx Assay for Gastrointestinal Illness

NEW YORK (GenomeWeb News) – Hologic said today that the US Food and Drug Administration has cleared its Prodesse ProGastro SSCS assay for marketing in the US.

Hologic acquired the technology when it bought Gen-Probe last summer. The real-time, multiplex PCR assay is for the qualitative detection of Salmonella, Shigella, and Campylobacter (C. jejuni and C.coli only undifferentiated) nucleic acids and Shiga Toxin 1 (stx1) and Shiga Toxin 2 (stx2) genes.

Hologic said the assay runs on a common benchtop instrument available in many labs and will provide results in hours. By comparison, culture tests may take 48 hours or more for results.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.